New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...

Ovacome, the UK’s ovarian cancer support charity, will host two events in Wales this August. 7,500 people are diagnosed with ...

Nomograms have a strong reputation as reliable predictive models that simplify statistical prediction models and guide ...

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

If you're concerned about breast cancer affecting you or someone close to you, this article can help you learn more about: ...

The actual numbers of young people with cancer are still low relative to older people, but they're unlikely to stay low. The ...

President Donald Trump has signed House Resolution 1 (H.R. 1), the final version of which does not impose a moratorium on state legislation governing the use of AI. The bill does, however, restore the ...

Dr Dinesh Pendharkar highlights how CAR T–cell therapy is reshaping cancer care in India by equipping the immune system with ...

Fibrolamellar hepatocellular carcinoma (FLC) has no approved treatment and occurs mostly in adolescents and young adults - KUALA LUMPUR, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel ...

Harvard Business School (HBS) has named its 2025-26 Blavatnik Fellows and the program’s twelfth cohort. Launched in 2013, the ...